Moderna, Inc. (MRNA)
49.04
-0.99
(-1.98%)
USD |
NASDAQ |
May 15, 16:00
48.88
-0.16
(-0.33%)
After-Hours: 20:00
Moderna EPS Diluted (Quarterly) : -3.40 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| Gilead Sciences, Inc. | 1.612 |
| Arbutus Biopharma Corp. | 0.8693 |
| AbbVie, Inc. | 0.3861 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.343B |
| Revenue (Quarterly) | 389.00M |
| Total Expenses (Quarterly) | 1.732B |
| Enterprise Value | 15.55B |
| Gross Profit Margin (Quarterly) | -160.7% |
| Profit Margin (Quarterly) | -345.2% |
| Earnings Yield | -16.61% |
| Normalized Earnings Yield | -16.61 |